Pathway-guided monitoring of the disease course in bladder cancer with longitudinal urine proteomics.
Luís Botelho CarvalhoJosé-Luis Capelo-MartínezCarlos LodeiroRajiv DhirLuis Campos PinheiroHugo López-FernándezGonçalo MartinsMariana MedeirosFernando DíazHugo Miguel SantosPublished in: Communications medicine (2023)
Using the information contained in the patient's urinary proteome, the dPPi reflects the individual's course of bladder cancer, and helps to optimise the use of more invasive procedures such as cystoscopy.